Efficacy of anti-influenza peptide vaccine in aged mice

Mechanisms of Ageing and Development

Volumn 104, Issue 1, 1998, Pages 11-23

  Ben Yedidia, Tamar ^a   Abel, Loya ^a   Arnon, Ruth ^a   Globerson, Amiela ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Influenza; Peptide; Vaccine

Indexed keywords

INFLUENZA VACCINE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; INTRANASAL DRUG ADMINISTRATION; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGING; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHICK EMBRYO; CYTOKINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

ANIMALIA; INFLUENZA VIRUS;

EID: 0032143344     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(98)00045-1     Document Type: Article

References (27)

1. Barrett, T., Inglis, S.C., 1985. Growth purification and titration influenza viruses. In: Mahy W.J. (Ed.), Virology: A Practical Approach. IRL Press, Washington, DC, pp. 119-151.
2. Beyer, W.E., Palache, A.M., Kerstens, R., Masurel, N., 1996. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur. J. Clin. Microbiol. Infect. Dis. 15, 65-70.
3. Bodnar, Z., Steger, M.M., Saurwein, T.M., Maczek, C., Grubeck, L.B., 1997. Cytokine production in response to stimulation with tetanus toxoid, Mycobacterium tuberculosis and influenza antigens in peripheral blood mononuclear cells and T cell lines from healthy elderlies. Int. Arch. Allergy Immunol. 112, 323-330.
4. Bullas, L.R., Ryu, J., 1983. Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156, 471-474.
5. Callahan, J.E., Kappler, J.W., Marrack, P., 1993. Unexpected expansion of CD8-bearing cells in old mice. J. Immunol. 151, 6657-6669.
6. Fagiolo, U., Amadori, A., Cozzi, E., Bendo, R., Lama, M., Douglas, A., Palu, G., 1993. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging (Milano) 5, 451-458.
7. + T cell help. J. Immunol. 147, 4069-4073.
8. Ganguly, R., Szewczuk, M.R., 1989. Age and immunity to respiratory tract infection. Age 12, 25-35.
9. Glathe, H., Lange, W., 1995. Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents. Drugs Aging 6, 368-387.
10. Globerson, A., 1995. T lymphocytes and aging. Int. Arch. Allergy Immunol. 107, 491-497.
11. Horwitz, R.J., Arnon, R., 1994. Influenza. In: Nicholson, B.D. (Ed.) Synthetic Vaccines. Blackwell, Oxford, pp. 471-493.
12. Ibrahim, G.F., Fleet, G.H., Lyons, M.L., Walter, R.A., 1985. Method for the isolation of highly purified Salmonella flagellin. J. Clin. Microbiol. 22, 1040-1044.
13. Kutza, J., Gross, P., Kaye, D., Murasko, D.M., 1996. Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin. Diagn. Lab. Immunol. 3, 105-108.
14. Levi, R., Arnon, R., 1995. Effective protection of mice from viral challenge by an influenza synthetic recombinant vaccine with cross strain specifity. In: Chanock, R.M. et al. (Eds.), Vaccines 95. CSHL Press, New York, pp. 311-316.
15. Levi, R., Arnon, R., 1996. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine 14, 85-92.
16. Levi, R., Aboud-Pirak, E., Leclerc, C., Lowell, G.H., Arnon, R., 1995. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine 13, 1353-1359.
17. Mbawuike, I.N., Lange, A.R., Couch, R.B., 1993. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunol. 6, 55-64.
18. Mbawuike, I.N., Acuna, C., Caballero, D., Pham, N.K., Gilbert, B., Petribon, P., Harmon, M., 1996. Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A. Cell. Immunol. 173, 64-78.
19. + T cells. Eur. J. Immunol. 21, 273-281.
20. Newton, S.M.C., Jacob, C.O., Stocker, B.A.D., 1989. Immune response to cholera toxin epitope inserted in Salmonella flagellin expression and live-vaccine potential. Science 244, 70-72.
21. Posnet, D.N., Sinha, R., Kabak, S., Russo, C., 1994. Clonal population of T-cells in normal elderly humans: the T-cell equivalent to 'benign monoclonal gammapathy'. J. Exp. Med. 179, 609-618.
22. Powers, D.C., Belshe, R.B., 1993. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 167, 584-592.
23. Provinciali, M., Di, S.G., Muzzioli, M., Scarpazza, P., Colombo, D., Migliorino, M., Bellani, M., Colombo, M., Della Croce, F., Gandolfi, M.C., 1994. Impaired antibody response to influenza vaccine in institutionalized elderly. Ann. New York Acad. Sci. 717, 307-314.
24. Sadoff, J.C., Ballou, W.R., Baron, L.R., Majarian, W.R., Brey, R.N., Hockmeyer, W.T., Young, J.F., Cryz, S.J., Ou, J., Lowell, G.H., Chulay, J.D., 1988. Oral Salmonella atyphimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240, 336-338.
25. Segall, R., Dayan, M., Globerson, A., Habut, B., Shearer, G.M., Mozes, E., 1997. Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus afflicted mice. Mech. Aging Dev. 96, 47-58.
26. Schmieger, H., 1972. Phage P22 mutants with increased or decreased transduction ability. Mol. Gen. Genet. 119, 75-88.
27. + T cells in respiratory virus infections. J. Immunol. 154, 6013-6021.